Currently holds positions in Cytokinetics Inc and Myriad Genetics Inc
Position | Company | Period |
---|---|---|
Independent Director | Cytokinetics Inc | Feb. 19, 2009 - |
Independent Director | Myriad Genetics Inc | March 23, 2020 - |
Independent Chairman of the Board | Myriad Genetics Inc | April 13, 2005 - March 23, 2020 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-25 | 2024-04-25 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
10,562
-24.8%
64.54681,671 USD |
10,562 -24.8% | 64.54 | 681,671 USD | |
2024-02-14 | 2024-02-14 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
5,000
-10.5%
76.48382,400 USD |
5,000 -10.5% | 76.48 | 382,400 USD | |
2024-01-12 | 2024-01-12 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
5,000
-10.5%
85.14425,700 USD |
5,000 -10.5% | 85.14 | 425,700 USD | |
2023-12-19 | 2023-12-18 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
2,458
-5.5%
36.3489,324 USD |
2,458 -5.5% | 36.34 | 89,324 USD | |
2023-05-15 | 2023-05-15 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
4,166
-14.1%
37.77157,350 USD |
4,166 -14.1% | 37.77 | 157,350 USD | |
2022-09-12 | 2022-09-12 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
7,259
-23.2%
54.94398,817 USD |
7,259 -23.2% | 54.94 | 398,817 USD | |
2022-09-12 | 2022-09-12 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
7,250
-23.2%
54.95398,402 USD |
7,250 -23.2% | 54.95 | 398,402 USD | |
2022-09-12 | 2022-09-12 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
7,250
-23.2%
54.94398,330 USD |
7,250 -23.2% | 54.94 | 398,330 USD | |
2021-11-05 | 2021-11-05 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
8,503
-39.1%
40.00340,120 USD |
8,503 -39.1% | 40.00 | 340,120 USD | |
2021-04-05 | 2021-04-01 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
1,100
-12.9%
23.3125,641 USD |
1,100 -12.9% | 23.31 | 25,641 USD | |
2021-04-05 | 2021-04-01 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
1,100
-12.9%
23.3125,641 USD |
1,100 -12.9% | 23.31 | 25,641 USD | |
2021-04-05 | 2021-04-01 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
1,133
-13.3%
24.0027,192 USD |
1,133 -13.3% | 24.00 | 27,192 USD | |
2020-10-05 | 2020-10-05 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
1,500
-62.5%
28.0042,000 USD |
1,500 -62.5% | 28.00 | 42,000 USD | |
2020-10-05 | 2020-10-05 |
Cytokinetics Inc
(CYTK)
|
PS Planned sale |
1,500
-62.5%
30.0045,000 USD |
1,500 -62.5% | 30.00 | 45,000 USD | |
2020-01-02 | 2019-11-19 |
Cytokinetics Inc
(CYTK)
|
B Purchase |
6,000
+2400.0%
8.5751,427 USD |
6,000 +2400.0% | 8.57 | 51,427 USD | |
2019-11-07 | 2019-11-07 |
Myriad Genetics Inc
(MYGN)
|
B Purchase |
1,750
+583.3%
23.4641,056 USD |
1,750 +583.3% | 23.46 | 41,056 USD | |
2019-11-07 | 2019-11-07 |
Myriad Genetics Inc
(MYGN)
|
B Purchase |
5,250
+8.9%
23.46123,167 USD |
5,250 +8.9% | 23.46 | 123,167 USD | |
2004-05-11 | 2004-05-11 |
Myriad Genetics Inc
(MYGN)
|
B Purchase |
2,000
+inf%
17.0334,060 USD |
2,000 +inf% | 17.03 | 34,060 USD |